[Topical felbinac in therapy of athletic injuries].

Abstract

In the treatment of acute soft tissue injuries, topical nonsteroidal anti-inflammatory drugs are both highly effective and well tolerated. Target is a monopreparation that meets the demands made on a modern topical agent. The active substance, felbinac, readily, penetrates into the tissue affected and accumulates locally, selectively inhibiting inflammation and alleviating pain. This synoptic report on the clinical trials confirm the significant clinical superiority of felbinac over placebo. As compared with piroxicam, felbinac, is more successful in eliminating symptoms. The rapid alleviation of pain by the topical felbinac results in an improvement in the restriction of mobility and rapid restitution of function. The cooling, nongreasy gel base further favors the high level of acceptance of this well-tolerated preparation.

• Authors: B Leeb
• Journal: Fortschritte der Medizin (Fortschr Med) Vol. 112 Issue 6 Pg. 77-80 (Feb 28 1994) ISSN: 0015-8178 [Print] Germany
• Vernacular Title: Topisches Felbinac in der Therapie von Sportverletzungen.
• PMID: 8163257 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Inflammatory Agents
• Gels
• Phenylacetates
• biphenylylacetic acid

Topics

• Administration, Topical
• Adolescent
• Adult
• Aged
• Anti-Inflammatory Agents (administration & dosage)
• Athletic Injuries (drug therapy)
• Child
• Contusions (drug therapy)
• Double-Blind Method
• Female
• Gels
• Humans
• Male
• Middle Aged
• Phenylacetates (administration & dosage)
• Pilot Projects
• Sprains and Strains (drug therapy)